<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03847532</url>
  </required_header>
  <id_info>
    <org_study_id>119</org_study_id>
    <nct_id>NCT03847532</nct_id>
  </id_info>
  <brief_title>MUTYH-associated Polyposis</brief_title>
  <acronym>MAP</acronym>
  <official_title>Diagnosis and Treatment of Russian Patients With MutYH-associated Polyposis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Scientific Centre of Coloproctology, Russian Federation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State Scientific Centre of Coloproctology, Russian Federation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is single-center, prospective, non-randomized study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include patients with more than 3 polyps, without mutations in the APC gene.
      Using molecular genetic research methods (polymerase chain reaction, SSCP, sequencing by
      Sanger method) mutations in the MutYH gene will be studied. For all patients with mutations
      in the MutYH gene, an optimal diagnostic algorithm will be developed. The significance of
      monoallelic mutations in the MutYH gene will be determined. Clinical monitoring will be
      defined. Optimal amount of surgical intervention will be suggested.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients with germIine mutations in MutYH</measure>
    <time_frame>from 0 to 6 months</time_frame>
    <description>number of patients with monoallelic and biallelic mutations in the MutYH-gene</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>MutYH-associated Polyposis</condition>
  <arm_group>
    <arm_group_label>Patients with mutations in the MutYH-gene</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with established diagnosis of MutYH-associated polyposis with monoallelic and biallelic mutations in the MutYH-gene</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with multiple colon polyps</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Number of polyps from 4+</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control sample</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who did not have colon polyps</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Sanger sequencing method</intervention_name>
    <description>Amplification of the examined fragments of the MutYH gene was conducted using the PCR machine TP4-PCR-01-Tertsik (DNA-Technology, Russia) containing 25 μL of the reaction mixture: 0.1-1.0 μg genomic DNA; 0.25 μM of each original oligoprimer; 200 μM of each nucleosidetriphosphate; 1 U Taq polymerase; PCR buffer (500 mM Tris, 500 mM KCl, pH 8.74); 2.5 μL MgCl2 (25 mM)); deionized water; 20-30 μL of mineral oil. For MutYH gene analysis (Transcript ENST00000257430) Primer3 software (http:// frodo.wi.mit.edu/primer3/input.htm) was selected and 16 primer pairs. The variants of the primary structure in the obtained fragments were revealed using SSCP. DNA fragments containing electrophoretically identified variants were sequenced.</description>
    <arm_group_label>Control sample</arm_group_label>
    <arm_group_label>Patients with multiple colon polyps</arm_group_label>
    <arm_group_label>Patients with mutations in the MutYH-gene</arm_group_label>
    <other_name>polymerase chain reaction</other_name>
    <other_name>SSCP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients with multiple colon polyps (n polyps = 4+)

          2. patient consent to participate in the study

        Exclusion Criteria:

          1. presence of mutations in the APC gene

          2. patient's refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>71 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alex Tsukanov, 37</last_name>
    <phone>+7 (499) 642 54 41</phone>
    <phone_ext>55420</phone_ext>
    <email>tsukanov81@rambler.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>State Scientific Centre of Coloproctology</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MutYH-associated polyposis</keyword>
  <keyword>familial adenomatous polyposis</keyword>
  <keyword>biallelic mutation</keyword>
  <keyword>monoallelic mutation</keyword>
  <keyword>colproctectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

